Clinical Trials on Disorders of Synovium, Multiple Sites
Total 26295 results
-
NYU Langone HealthCompleted
-
IRCCS San RaffaeleFondazione Italiana Sclerosi MultiplaCompletedProgressive Multiple SclerosisItaly
-
Aristotle University Of ThessalonikiGreek Alzheimer's Association and Related Disorders; Ellis-Farm, Eliama Daily...CompletedProgressive Multiple SclerosisGreece
-
Duke UniversityCompletedPrimary Progressive Multiple SclerosisUnited States
-
Rigshospitalet, DenmarkBiogenCompletedPrimary Progressive Multiple SclerosisDenmark
-
MedDay Pharmaceuticals SATerminatedMultiple SclerosisUnited States, Spain, Canada, Australia, United Kingdom, Belgium, Turkey, Czechia, Poland, Italy, Hungary, Germany, Sweden
-
South Valley UniversityCompleted
-
University Hospital, BordeauxCompletedMultiple Sclerosis | Multiple Sclerosis, Acute RelapsingFrance
-
Genentech, Inc.No longer availableMultiple SclerosisUnited States
-
Novartis PharmaceuticalsTerminatedPrimary Progressive Multiple SclerosisUnited States, Belgium, Poland, Germany, Hungary, Turkey, Spain, Australia, Canada, Czechia, Switzerland, United Kingdom, Netherlands, France, Italy, Denmark, Finland, Sweden
-
BayerBiogen Netherlands B.V; Novartis Europharm Limited; Merck Europe B.V.Not yet recruitingMultiple Sclerosis (MS)Sweden, Finland
-
Assistance Publique Hopitaux De MarseilleUnknownMultiple Sclerosis (MS)France
-
Muğla Sıtkı Koçman UniversityCompletedMultiple Sclerosis | Telerehabilitation | Autoimmune Disorder | Exercise ProgramTurkey
-
University of WashingtonNational Cancer Institute (NCI)TerminatedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)TerminatedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
National Cancer Institute (NCI)CompletedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
Hellenic Red Cross HospitalG.Gennimatas General HospitalCompletedDepression | Stroke | Quality of Life | Multiple Sclerosis | Mental Health DisorderGreece
-
University College, LondonLondon School of Hygiene and Tropical Medicine; The Leeds Teaching Hospitals... and other collaboratorsActive, not recruitingSecondary Progressive Multiple Sclerosis (SPMS)United Kingdom
-
Teva Branded Pharmaceutical Products R&D, Inc.Withdrawn
-
Réseau Sep Idf OuestCompletedFatigue | Relapsing Remitting Multiple Sclerosis | Cognitive TherapyFrance
-
BayerWithdrawnMultiple SclerosisSweden, Denmark
-
Dr. Luanne MetzMultiple Sclerosis Society of CanadaCompletedClinically Isolated Syndromes | Early Single Relapse of Multiple SclerosisCanada
-
National Cancer Institute (NCI)Active, not recruitingSmoldering Multiple Myeloma | Refractory Multiple Myeloma | DS Stage I Multiple Myeloma | DS Stage II Multiple Myeloma | DS Stage III Multiple MyelomaUnited States
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)RecruitingMonoclonal Gammopathy of Undetermined Significance | Smoldering Multiple MyelomaUnited States
-
Case Comprehensive Cancer CenterWithdrawnMyeloma | Smoldering Myeloma | Monoclonal GammopathyUnited States
-
Roswell Park Cancer InstituteCelgeneActive, not recruitingPlasma Cell Myeloma | Partial Response of Multiple Myeloma or Plasma Cell LeukemiaUnited States
-
National Cancer Institute (NCI)TerminatedMonoclonal Gammopathy of Undetermined Significance | Smoldering MyelomaUnited States
-
Dana-Farber Cancer InstituteCompletedMonoclonal Gammopathy of Undetermined Significance | Smoldering Multiple MyelomaUnited States
-
McGill UniversityCompletedMultiple Sclerosis, Relapsing-RemittingCanada
-
BayerCompletedMultiple Sclerosis, Relapsing-RemittingUnited States
-
University of WashingtonCompletedQuality of Life | Multiple Sclerosis | Fatigue | Activity, MotorUnited States
-
Istanbul University - Cerrahpasa (IUC)Active, not recruitingQuality of Life | Multiple Sclerosis | Fatigue | Sleep HygieneTurkey
-
NYU Langone HealthNational Cancer Institute (NCI)TerminatedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Thrombocytopenia | Refractory Multiple MyelomaUnited States
-
University of UtahRecruitingMultiple Sclerosis | Major Depressive Disorder | Treatment Resistant DepressionUnited States
-
Shirley Ryan AbilityLabNorthwestern UniversityNot yet recruitingMultiple Sclerosis | Multiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary ProgressiveUnited States
-
Stanford UniversityKyverna TherapeuticsRecruitingMultiple Sclerosis | Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary ProgressiveUnited States
-
Abu Dhabi Stem Cells CenterRecruitingMultiple Sclerosis | Multiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary ProgressiveUnited Arab Emirates
-
Emmanuelle Waubant, MD PhDUnited States Department of DefenseRecruitingMultiple Sclerosis | Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary ProgressiveUnited States
-
BioMS Technology Corp.TerminatedMultiple Sclerosis, Secondary Progressive
-
University Hospital of Mont-GodinneSaint-Luc University HospitalRecruitingMultiple Sclerosis, Relapsing-RemittingBelgium
-
Novartis PharmaceuticalsRecruitingRelapsing Multiple SclerosisAustralia
-
Kessler FoundationCelgene; Hackensack Meridian Health; St. Barnabas Medical CenterRecruitingMultiple Sclerosis, Relapsing-RemittingUnited States
-
University of NebraskaCompletedMultiple Sclerosis, Relapsing-RemittingUnited States
-
BiogenCompleted
-
GlaxoSmithKlineCompletedMultiple Sclerosis, Relapsing-RemittingAustralia
-
GlaxoSmithKlineCompletedMultiple Sclerosis, Relapsing-RemittingAustralia
-
Novo Cellular Medicine Institute LLPUnknownMultiple Sclerosis, Relapsing-RemittingIndia, Trinidad and Tobago
-
Centre Hospitalier Universitaire VaudoisBioPartners GmbHCompletedMultiple Sclerosis, Relapsing-Remitting
-
Centre Hospitalier Universitaire VaudoisBioPartners GmbHCompletedMultiple Sclerosis, Relapsing-Remitting